Sotera Health Company (SHC)
NASDAQ: SHC · IEX Real-Time Price · USD
11.29
-0.12 (-1.05%)
At close: May 17, 2024, 4:00 PM
10.98
-0.31 (-2.75%)
After-hours: May 17, 2024, 5:17 PM EDT
Sotera Health Company Market Cap
Sotera Health Company has a market cap or net worth of $3.20 billion as of May 17, 2024. Its market cap has decreased by -23.41% in one year.
Market Cap
3.20B
Enterprise Value
5.28B
1-Year Change
-23.41%
Ranking
Category
Stock Price
$11.29
Market Cap Chart
Since the IPO on November 20, 2020, Sotera Health Company's market cap has decreased from $6.42B to $3.20B, a decrease of -50.20%. That is a compound annual growth rate of -18.10%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 3.20B | -1.05% |
May 16, 2024 | 3.23B | - |
May 15, 2024 | 3.23B | 0.09% |
May 14, 2024 | 3.23B | 0.18% |
May 13, 2024 | 3.22B | 3.08% |
May 10, 2024 | 3.13B | -2.56% |
May 9, 2024 | 3.21B | 1.03% |
May 8, 2024 | 3.17B | -2.22% |
May 7, 2024 | 3.25B | 1.59% |
May 6, 2024 | 3.20B | 2.45% |
May 3, 2024 | 3.12B | 1.01% |
May 2, 2024 | 3.09B | -3.11% |
May 1, 2024 | 3.19B | 0.63% |
Apr 30, 2024 | 3.17B | -1.58% |
Apr 29, 2024 | 3.22B | -0.18% |
Apr 26, 2024 | 3.22B | 0.71% |
Apr 25, 2024 | 3.20B | 0.45% |
Apr 24, 2024 | 3.19B | -0.97% |
Apr 23, 2024 | 3.22B | 2.61% |
Apr 22, 2024 | 3.14B | 1.28% |
Apr 19, 2024 | 3.10B | 0.46% |
Apr 18, 2024 | 3.08B | 1.40% |
Apr 17, 2024 | 3.04B | -1.29% |
Apr 16, 2024 | 3.08B | -1.09% |
Apr 15, 2024 | 3.11B | -2.39% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Ultragenyx Pharmaceutical | 3.42B |
SpringWorks Therapeutics | 3.35B |
Prestige Consumer Healthcare | 3.30B |
Biohaven Pharmaceutical Holding Company | 3.24B |
Envista Holdings | 3.24B |
IDEAYA Biosciences | 3.21B |
10x Genomics | 3.16B |
Summit Therapeutics | 3.15B |